{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:20:19Z","timestamp":1785396019114,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s10875-005-2816-0","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T11:24:28Z","timestamp":1112959468000},"page":"106-115","source":"Crossref","is-referenced-by-count":40,"title":["Lower CD4+ T Lymphocyte Nadirs May Indicate Limited Immune Reconstitution in HIV-1 Infected Individuals on Potent Antiretroviral Therapy: Analysis of Immunophenotypic Marker Results of AACTG 5067"],"prefix":"10.1007","volume":"25","author":[{"given":"Ronald","family":"D\u2019Amico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Mildvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol T.","family":"Schnizlein-Bick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Basar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zackin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2816_CR1","unstructured":"Moore RD, Keruly JC, Chaisson RE: Decline in CMV and other opportunistic diseases with combination antiretroviral therapy [abstract 184]. In Program and Abstracts of the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1\u20135, 1998"},{"key":"2816_CR2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella","year":"1998","unstructured":"Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 338:853\u2013860, 1998","journal-title":"New Engl J Med"},{"key":"2816_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00126334-199905010-00008","volume":"21","author":"MA Chiasson","year":"1999","unstructured":"Chiasson MA, Berenson L, Li W, Schwartz S, Singh T, Forlenza S, Mojica BA, Hamburg MA: Declining HIV\/AIDS mortality in New York City. J Acquir Immune Defic Syndr 21:59\u201364, 1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2816_CR4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1086\/379901","volume":"188","author":"RL Hengel","year":"2003","unstructured":"Hengel RL, Kovacs JA: Surrogate markers of immune function in human immunodeficiency virus-infected patients: What are they surrogates for? J Infect Dis 188:1791\u20131793, 2003","journal-title":"J Infect Dis"},{"key":"2816_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/infdis\/173.2.321","volume":"173","author":"AD Kelleher","year":"1996","unstructured":"Kelleher AD, Carr A, Zaunders J, Cooper DA: Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 173:321\u2013329, 1996","journal-title":"J Infect Dis"},{"key":"2816_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","volume":"277","author":"B Autran","year":"1997","unstructured":"Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112\u2013116, 1997","journal-title":"Science"},{"key":"2816_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1086\/515591","volume":"178","author":"M Lederman","year":"1998","unstructured":"Lederman M, Connick E, Landay A, Kuritzkes D, Spritzler J, St Clair M, Kotzin B, Fox L, Heath-Chiozzi M, Leonard J, Rousseau F, Wade M, D\u2019Arc-Roe J, Martinez A, Kessler H: Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of the AIDS Clinical trial group protocol 315. J Infect Dis 178:70\u201379, 1998","journal-title":"J Infect Dis"},{"key":"2816_CR8","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/379900","volume":"188","author":"HM Lederman","year":"2003","unstructured":"Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ, Currier JS, for the AIDS Clinical Trials Group 889 Study Team: Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis 188:1794\u20131803, 2003","journal-title":"J Infect Dis"},{"key":"2816_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002030-199902040-00008","volume":"13","author":"NG Pakker","year":"1999","unstructured":"Pakker NG, Kroon E, Roos M, Otto S, Hall D, Wit F, Hamann D, van der Ende M, Claessen F, Kauffmann R, Koopmans P, Kroon F, ten Napel C, Sprenger H, Weigel H, Montaner J, Lange J, Reiss P, Schellekens P, Miedema F for the INCAS Study Group: Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. AIDS 13:203\u2013212, 1999","journal-title":"AIDS"},{"key":"2816_CR10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/00002030-199907090-00006","volume":"13","author":"I Mezzaroma","year":"1999","unstructured":"Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori S, Bernardi M, Paganelli R, Aiuti F: Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 13:1187\u20131193, 1999","journal-title":"AIDS"},{"issue":"A","key":"2816_CR11","first-page":"S25","volume":"13","author":"JC Gea-Banacloche","year":"1999","unstructured":"Gea-Banacloche JC, Lane HC: Immune reconstitution in HIV infection. AIDS 13(A): S25\u2013S38, 1999","journal-title":"AIDS"},{"key":"2816_CR12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00002030-200209270-00002","volume":"16","author":"H Valdez","year":"2002","unstructured":"Valdez H, Connick E, Smith K, Lederman MM, Bosch R, Kim R, St Clair M, Kuritzkes D, Kessler H, Fox L, Blanchard-Vargas M, Landay A for the AIDS clinical trials group protocol 375 team: Limited immune restoration after 3 years\u2019 suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 16:1859\u20131866, 2002","journal-title":"AIDS"},{"key":"2816_CR13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI5863","volume":"103","author":"RP Bucy","year":"1999","unstructured":"Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, Mitsuyasu RT, Kilby JM: Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 103:1391\u20131398, 1999","journal-title":"J Clin Invest"},{"issue":"2","key":"2816_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jama.284.2.223","volume":"284","author":"MM Lederman","year":"2000","unstructured":"Lederman MM, Valdez H: Immune restoration with antiretroviral therapies: Implications for clinical management. JAMA 284(2):223\u2013228, 2000","journal-title":"JAMA"},{"key":"2816_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2249.2000.01153.x","volume":"119","author":"H Choremi-Papadopoulou","year":"2000","unstructured":"Choremi-Papadopoulou H, Panagiootou N, Samouilidou E, Kontopidou F, Viglis V, Antoniadou A, Kosmidis J, Kordossis T: CD28 co-stimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS. Clin Exp Immunol 119:499\u2013506, 2000","journal-title":"Clin Exp Immunol"},{"key":"2816_CR16","unstructured":"Koretzky GA, Peterson EJ: T cell activation and inactivation. In Clinical Immunology: Principles and Practice, Robert Rich (ed). UK, Mosby International Limited, 2001, Section 1, Chapter 10, pp 10.1\u201310.15"},{"key":"2816_CR17","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1086\/375239","volume":"187","author":"S Ostrowski","year":"2003","unstructured":"Ostrowski S, Gerstoft J, Pedersen B, Ullum H: A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients. J Infect Dis 187:1726\u20131734, 2003","journal-title":"J Infect Dis"},{"key":"2816_CR18","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00002030-200309260-00002","volume":"17","author":"CG Lange","year":"2003","unstructured":"Lange CG, Lederman MM, Medvik K, Asaad R, Wild M, Kalayjian R, Valdez H: Nadir CD4+ T-cell count and numbers of CD28+CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS 17:2015\u20132023, 2003","journal-title":"AIDS"},{"key":"2816_CR19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/00002030-200108170-00008","volume":"15","author":"SL Koletar","year":"2001","unstructured":"Koletar SL, Heald AE, Finkelstein D, Hafner R, Currier JS, McCutchan JA, Vallee M, Torriani FJ, Powderly WG, Fass RJ, Murphy RL for the ACTG 888 Study Team: A prospective study of discontinuing primary and secondary Pneumocystis carinii prophylaxis after CD4+ counts increase to >200 cells\/mm3. AIDS 15:1509\u20131515, 2001","journal-title":"AIDS"},{"key":"2816_CR20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00126334-200012010-00002","volume":"25","author":"C Tortajada","year":"2000","unstructured":"Tortajada C, Garcia F, Plana M, Gallart T, Maleno M, Miro J, Gatell J: Comparison of T-cell subsets\u2019 reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease. J Acquir Immune Defic Syndr 25:296\u2013305, 2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2816_CR21","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1097\/00002030-200012010-00003","volume":"14","author":"GR Kaufmann","year":"2000","unstructured":"Kaufmann GR, Zaunders J, Cunningham P, Kelleher A, Grey P, Smith D, Carr A, Cooper D: Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. AIDS 14:2643\u20132651, 2000","journal-title":"AIDS"},{"key":"2816_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","volume":"130","author":"V Miller","year":"1999","unstructured":"Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos A, Katzenstein T, van Lunzen J, Antunes F, Phillips A, Lundgren J for the EuroSIDA study group: Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study. Ann Intern Med 130:570\u2013577, 1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"2816_CR23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/clim.2001.5164","volume":"102","author":"CG Lange","year":"2002","unstructured":"Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM: CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin Immunol 102(2):154\u2013161, 2002","journal-title":"Clin Immunol"},{"key":"2816_CR24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00042560-199712150-00002","volume":"16","author":"NG Pakker","year":"1997","unstructured":"Pakker NG, Roos MT, van Leeuwen R, de Jong MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, Schellekens PT: Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. J Acquir Immune Defic Syndr Human Retro 16:318\u2013326, 1997","journal-title":"J Acquir Immune Defic Syndr Human Retro"},{"key":"2816_CR25","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","volume":"351","author":"TS Li","year":"1998","unstructured":"Li TS, Tubiana R, Katlama C, Calvez V, Mohand H, Autran B: Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351:1682\u20131686, 1998","journal-title":"Lancet"},{"key":"2816_CR26","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/00002030-200012010-00002","volume":"14","author":"M Lederman","year":"2000","unstructured":"Lederman M, McKinnis R, Kelleher D, Cutrell A, Mellors J, Niesler M, Cooney E, Haas D, Haubrich R, Stanford J, Horton J, Landay A, Spreen W: Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: Age inversely predicts na\u00edve CD4 cell count increase. AIDS 14:2635\u20132642, 2000","journal-title":"AIDS"},{"key":"2816_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-200001070-00002","volume":"14","author":"H Valdez","year":"2000","unstructured":"Valdez H, Smith KY, Landay A, Connick E, Kuritzkes D, Kessler H, Fox L, Spritzler J, Roe J, Lederman MB, Lederman HM, Evans T, Heath-Chiozzi M, Lederman MM, and the ACTG 375 team: Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. AIDS 14:11\u201321, 2000","journal-title":"AIDS"},{"key":"2816_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","volume":"360","author":"M Egger","year":"2002","unstructured":"Egger M, May M, Chene G, Phillips A, Ledergerber B, Dabis F, Costagliola D, Monforte A, deWolf F, Reiss P, Lundgren J, Justice A, Staszewski S, Leport C, Hogg R, Sabin C, Gill M, Salzberger B, Sterne J, and the ART Cohort Collaboration: Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 360:119\u2013127, 2002","journal-title":"Lancet"},{"key":"2816_CR29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/infdis\/169.4.730","volume":"169","author":"JE Brinchmann","year":"1994","unstructured":"Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T: Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: Functional and clinical correlations. J Infect Dis 169:730\u2013738, 1994","journal-title":"J Infect Dis"},{"key":"2816_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2249.1996.d01-794.x","volume":"105","author":"MT Roos","year":"1996","unstructured":"Roos MT, Miedema F, Meinesz AP, DeLeeuw NA, Pakker NG, Lange JM, Coutinho RA, Schellekens PT: Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: Correlation with decreased CD28 expression. Clin Exp Immunol 105:409\u2013415, 1996","journal-title":"Clin Exp Immunol"},{"key":"2816_CR31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00126334-199908150-00004","volume":"21","author":"SR Sondergaard","year":"1999","unstructured":"Sondergaard SR, Aladdin H, Ullum H, Gerstoft J, Skinhoj P, Pedersen B: Immune function and phenotype before and after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 21:376\u2013383, 1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2816_CR32","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","volume":"102","author":"M Hakki","year":"2003","unstructured":"Hakki M, Riddell S, Storek J, Carter R, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M: Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: Impact of host factors, drug therapy, and subclinical reactivation. Blood 102:3060\u20133067, 2003","journal-title":"Blood"},{"key":"2816_CR33","unstructured":"Ware R: Immune abnormalities secondary to infectious diseases. In Clinical Immunology: Principles and Practice, Robert Rich (ed). UK, Mosby International Limited, 2001, Section 4, Chapter 43, pp 43.1\u201343.7"},{"key":"2816_CR34","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/173.4.1034","volume":"173","author":"H Marcotte","year":"1996","unstructured":"Marcotte H, Levesque D, Delanay K, Bourgeault A, de la Durantaye R, Brochu S, Lavoie M: Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis 173:1034\u20131037, 1996","journal-title":"J Infect Dis"},{"key":"2816_CR35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.301657","volume":"197","author":"PD Walzer","year":"1977","unstructured":"Walzer PD, Schnelle V, Armstrong D, Rosen PP: The nude mouse: A new experimental model for Pneumocystis carinii infection. Science 197:177\u2013179, 1977","journal-title":"Science"},{"key":"2816_CR36","first-page":"206","volume":"118","author":"PD Walzer","year":"1991","unstructured":"Walzer PD: Immunopathogenesis or Pneumocystis carinii infection. J Lab Clin Med 118:206\u2013216, 1991","journal-title":"J Lab Clin Med"},{"key":"2816_CR37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.172.3.937","volume":"172","author":"AG Harmsen","year":"1990","unstructured":"Harmsen AG, Stankiewicz M: Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 172:937\u2013945, 1990","journal-title":"J Exp Med"},{"key":"2816_CR38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/514542","volume":"25","author":"MH Kulke","year":"1997","unstructured":"Kulke MH, Vance EA: Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 25:215\u2013218, 1997","journal-title":"Clin Infect Dis"},{"key":"2816_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199302113280601","volume":"328","author":"D Smith","year":"1999","unstructured":"Smith D, Neal J, Holmberg S, and the Centers for Disease Control Idiopathic CD4+ T- lymphocytopenia task force: Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. New Engl J Med 328:373\u2013379, 1999","journal-title":"New Engl J Med"},{"key":"2816_CR40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","volume":"322","author":"J Phair","year":"1990","unstructured":"Phair J, Munoz A, Detels R: The risk of Pneumocystis carinii pneumonia among men infected with immunodeficiency virus type 1. New Engl J Med 322:161\u2013165, 1990","journal-title":"New Engl J Med"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-005-2816-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-005-2816-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-005-2816-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:09:55Z","timestamp":1559275795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-005-2816-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["2816"],"URL":"https:\/\/doi.org\/10.1007\/s10875-005-2816-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}